
1 min read
Veranex’s Model Assesses EXENT® GAM Assay* Savings in Myeloma Patient Monitoring
The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass spectrometry method that may replace current immunofixation testing and may inform the timing of bone...
Read More